Indomethacin-mediated enhancement of lymphocyte response to mitogens; in treated and untreated Hodgkin's disease and non-Hodgkin's lymphoma.
D000328:Adult; D000368:Aged; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology* / Q000627:therapeutic use; D007376:Interleukin-2 / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008222:Lymphokines / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects; D013268:Stimulation, Chemical
D007376:Interleukin-2; D008222:Lymphokines; D008934:Mitogens; D007213:Indomethacin